Literature DB >> 24257464

Hypoxic stress, brain vascular system, and β-amyloid: a primary cell culture study.

Abebe Muche, Susanne Bürger, Thomas Arendt, Reinhard Schliebs.   

Abstract

This study stresses the hypothesis whether hypoxic events contribute to formation and deposition of β-amyloid (Aβ) in cerebral blood vessels by affecting the processing of endothelial amyloid precursor protein (APP). Therefore, cerebral endothelial cells (ECs) derived from transgenic Tg2576 mouse brain, were subjected to short periods of hypoxic stress, followed by assessment of formation and secretion of APP cleavage products sAPPα, sAPPβ, and Aβ as well as the expression of endothelial APP. Hypoxic stress of EC leads to enhanced secretion of sAPPβ into the culture medium as compared to normoxic controls, which is accompanied by increased APP expression, induction of vascular endothelial growth factor (VEGF) synthesis, nitric oxide production, and differential changes in endothelial p42/44 (ERK1/2) expression. The hypoxia-mediated up-regulation of p42/44 at a particular time of incubation was accompanied by a corresponding down-regulation of the phosphorylated form of p42/44. To reveal any role of hypoxia-induced VEGF in endothelial APP processing, ECs were exposed by VEGF. VEGF hardly affected the amount of sAPPβ and Aβ(1-40) secreted into the culture medium, whereas the suppression of the VEGF receptor action by SU-5416 resulted in decreased release of sAPPβ and Aβ(1-40) in comparison to control incubations, suggesting a role of VEGF in controlling the activity of γ-secretase, presumably via the VEGF receptor-associated tyrosine kinase. The data suggest that hypoxic stress represents a mayor risk factor in causing Aβ deposition in the brain vascular system by favoring the amyloidogenic route of endothelial APP processing. The hypoxic-stress-induced changes in β-secretase activity are presumably mediated by altering the phosphorylation status of p42/44, whereas the stress-induced up-regulation of VEGF appears to play a counteracting role by maintaining the balance of physiological APP processing.

Entities:  

Keywords:  Amyloid precursor protein; Brain vascular endothelial cell; ELISA; Primary cell culture; SU-5416; Tg2576 mouse; VEGF

Mesh:

Substances:

Year:  2013        PMID: 24257464     DOI: 10.1179/1476830513Z.000000000112

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  6 in total

Review 1.  Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.

Authors:  Livius V d'Uscio; Tongrong He; Zvonimir S Katusic
Journal:  Physiology (Bethesda)       Date:  2017-01

Review 2.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 3.  Cognitive and Functional Consequence of Cardiac Arrest.

Authors:  Claudia A Perez; Niyatee Samudra; Venkatesh Aiyagari
Journal:  Curr Neurol Neurosci Rep       Date:  2016-08       Impact factor: 5.081

Review 4.  Hypoxia in CNS Pathologies: Emerging Role of miRNA-Based Neurotherapeutics and Yoga Based Alternative Therapies.

Authors:  Gillipsie Minhas; Deepali Mathur; Balakrishnan Ragavendrasamy; Neel K Sharma; Viraaj Paanu; Akshay Anand
Journal:  Front Neurosci       Date:  2017-07-11       Impact factor: 4.677

5.  Oxidative stress affects processing of amyloid precursor protein in vascular endothelial cells.

Authors:  Abebe Muche; Thomas Arendt; Reinhard Schliebs
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

6.  Gintonin-mediated release of astrocytic vascular endothelial growth factor protects cortical astrocytes from hypoxia-induced cell damages.

Authors:  Sun-Hye Choi; Hyeon-Joong Kim; Hee-Jung Cho; Sang-Deuk Park; Na-Eun Lee; Sung-Hee Hwang; Hyewon Rhim; Hyoung-Chun Kim; Ik-Hyun Cho; Seung-Yeol Nah
Journal:  J Ginseng Res       Date:  2018-05-31       Impact factor: 6.060

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.